University of Nottingham spinout Neupulse secures £500K investment

Neupulse, a University of Nottingham spinout, has secured a £500,000 equity investment through the Midlands Engine Investment Fund II, facilitated by Mercia Ventures, the appointed fund manager for the East and South East Midlands.

Founded in 2021 by husband and wife team, Professors Stephen and Georgina Jackson, with Dr Barbara Morera at the University of Nottingham, Neupulse is pioneering a safe, non-drug treatment to help manage the symptoms of Tourette’s syndrome.

The wristband device stimulates the median nerve in the wrist to help control the tics or involuntary movements caused by Tourette’s syndrome. Clinical trials have shown the device can reduce tic frequency by an average of 25% on initial use, with a further reduction in frequency after four weeks of use.

The funding will enable the company to finalise development of its device and carry out further trials as it seeks to gain regulatory approvals in the UK, Europe, and the USA. It follows a £2.5 million investment earlier this year from a consortium including Eos Advisory and US-based investors, bringing the total the company has raised to date to almost £4.5 million.

The £400 million Midlands Engine Investment Fund II covers the entire Midlands region and aims to drive sustainable economic growth by supporting innovation and creating local opportunities for new and growing businesses across the Midlands.